Innocan Pharma Corp. Stock
€4.52
Your prediction
Financial data and news for Innocan Pharma Corp.
sharewise wants to provide you with the best news and tools for Innocan Pharma Corp., so we directly link to the best financial data sources.
Financials
News
Innocan Pharma Announces Promising Translational Evidence from a Pain Relief Study of Repeated LPT-CBD Administration in Goats
Herzliya, Israel and Calgary, Alberta – 24 November 2025 – Innocan Pharma Corporation (CSE: INNO) (FSE: IP40) (OTCQB: INNPD) (“Innocan” or the “Company”), a pioneer in the pharmaceutical and
Innocan Pharma Reports Financial Results for Q3 2025, with Revenues at US $21.6M
Herzliya, Israel and Calgary, Alberta – November 27, 2025 – Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the “Company” or “Innocan”), a pharmaceutical technology company
Innocan Pharma announces promising results of LPT-CBD administered to Gottingen Minipigs, a well-known drug toxicology model
Herzliya, Israel and Calgary, Alberta –20 November, 2025 – Innocan Pharma Corporation (CSE: INNO) (FSE: IP40) (OTCQB: INNPD) (“Innocan” or the “Company”), a pioneer in the pharmaceutical and
Innocan Pharma to Present at the 2025 ThinkEquity Conference
Herzliya, Israel and Calgary, Alberta – October 24, 2025 – Innocan Pharma Corporation (CSE: INNO) (FSE: IP40) (OTCQB: INNPF) (“Innocan” or the “Company”), a pioneer in the pharmaceutical and
Liposomal CBD Injection Technology (LPT-CBD) Patent Was Allowed in Japan
Innovative Chronic Pain Treatment Receives allowance for IP Protection in Japan’s World Third Largest Pharmaceutical Market
Herzliya, Israel and Calgary, Alberta – October 15, 2025 –
Innocan Pharma Partners With a Sanctuary For Injured Animals to Bring Remedy and Hope with its LPT-CBD injection
Herzliya, Israel and Calgary, Alberta – Sep 19, 2025 – Innocan Pharma Corporation (CSE: INNO) (FSE: IP40) (OTCQB: INNPF) (“Innocan” or the “Company”), a pioneer in the pharmaceutical and
Innocan Pharma’s Poster on its Liposomal Synthetic CBD Technology Generates Interest at PAINWeek Conference
Herzliya, Israel and Calgary, Alberta – Sep 15, 2025 – Innocan Pharma Corporation (CSE: INNO) (FSE: IP40) (OTCQB: INNPF) (“Innocan” or the “Company”), a pioneer in the pharmaceutical and